Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Method of determining the sensitivity of cancer cells to EGFR inhibitors including cetuximab, panitumumab and erlotinib

Method of determining the sensitivity of cancer cells to EGFR inhibitors including cetuximab, panitumumab and erlotinib

US Patent 8137919 · Granted Mar 20, 2012

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Markers for selecting personalized therapies for the treatment of cancer2015
Unitary packaging system for a capacitor and inductor1998
Variable voltage, variable capacitance chip capacitor device having lead pins el1997
Electrochemical cell1996